Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 14461–14480 of 17,529 recalls

July 24, 2014· Fagron, Inc

Recalled Item: Fagron

The Issue: Microbial Contamination of Non-Sterile Products: Fagron is recalling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 24, 2014· Physician Preferred Medical, LLC

Recalled Item: Epel 18 mg Estradiol Pellet

The Issue: Non-Sterility: The recalled lot failed sterility testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 18, 2014· Spectrum Laboratory Products

Recalled Item: Tetrahydrozoline Hydrochloride

The Issue: CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2014· Unique Pharmaceutical, Ltd

Recalled Item: All sterile products within expiry

The Issue: Lack of Sterility Assurance: A recent FDA inspection

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2014· Unique Pharmaceutical, Ltd

Recalled Item: N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133

The Issue: Non-Sterility: One lot of N-Acetyl Cysteine vials tested

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 17, 2014· X-Gen Pharmaceuticals Inc.

Recalled Item: Clonidine HCl Injection

The Issue: Labeling: Label Error On Declared Strength: The side

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 17, 2014· SST Corporation

Recalled Item: Tetrahydrozoline HCL

The Issue: CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 16, 2014· Bio-pharm, Inc.

Recalled Item: Rugby Children's Pain and Fever Acetaminophen Oral Suspension 160 mg/5 mL

The Issue: Superpotent Drug: Bio-Pharm, Inc. is initiating a recall

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 15, 2014· Noven Pharmaceuticals, Inc.

Recalled Item: Daytrana (methylphenidate transdermal system) patch

The Issue: Defective Delivery System: Out of Specification (OOS) results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 14, 2014· Wockhardt Usa Inc.

Recalled Item: buPROPion HCl Extended-Release Tablets

The Issue: Failed Impurities/Degradation Products: Out of specification levels of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Benicar Tablets (olmesartan medoxomil) 20 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Benicar HCT Tablets (olmesartan medoxomil

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Benicar Tablets (olmesartan medoxomil) 40 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Welchol Tablets (colesevelam HCl) 625 mg

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 12, 2014· Daiichi Sankyo Pharma Development

Recalled Item: Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide)

The Issue: Temperature Abuse; various products were not stored at

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 11, 2014· Baxter Healthcare Corp.

Recalled Item: Potassium Chloride Injection

The Issue: Presence of Particulate Matter: particulate matter identified as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 11, 2014· Baxter Healthcare Corp.

Recalled Item: 0.9% Sodium Chloride Injection USP MINI-BAG Plus Container

The Issue: Presence of Particulate Matter: particulate matter identified as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund